Charts
Using Targeted Therapies in a Real-World SettingEpisode from the podcastUsing Targeted Therapies in a Real-World Setting
Using Targeted Therapies in a Real-World Setting - Part 2

Using Targeted Therapies in a Real-World Setting - Part 2

Released Thursday, 29th April 2010
Good episode? Give it some love!
Using Targeted Therapies in a Real-World Setting - Part 2

Using Targeted Therapies in a Real-World Setting - Part 2

Using Targeted Therapies in a Real-World Setting - Part 2

Using Targeted Therapies in a Real-World Setting - Part 2

Thursday, 29th April 2010
Good episode? Give it some love!
Rate Episode
List
About
InsightsPodchaser Pro
Reviews
Credits
Lists
Transcript

The experts discuss the continued use of bevacizumab and/or other targeted agents in treating recurrent disease.

Show More
Rate
List
Get this podcast via API

From The Podcast

In this engaging podcast, Drs. Bradley Monk and Robert Burger discuss important practical issues regarding the use of antiangiogenic therapy to treat epithelial ovarian cancer, including the possible value of targeted agents as maintenance therapy, the correct dosage and duration of targeted therapy, and the role of CA125 in determining tumor progression with a biologic agent

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more
Do you host or manage this podcast?
Claim and edit this page to your liking.
,
Podchaser Logo

Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More